Eckert & Ziegler SEXTER:EUZ -0.65%98 Interest Coverage is 15.27 as of Mar. 2026, which is 33% below its 10-year median of 22.82. GuruFocus rates XTER:EUZ with a GF Score™ of 98/100 and a GF Value™ of €16.25 (Fairly Valued). Among 466 Medical Devices & Instruments companies, Eckert & Ziegler SE ranks worse than 50.21% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Eckert & Ziegler SE's
Operating Income
for the
three
months ended in Mar. 2026 was €16.0 Mil. Eckert & Ziegler SE's Interest Expense for the
three
months ended in Mar. 2026 was €-1.0 Mil.
Eckert & Ziegler SE's interest coverage for the quarter that ended in Mar. 2026 was 15.27.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Eckert & Ziegler SE's Interest Coverage or its related term are showing as below:
XTER:EUZ'
s Interest Coverage Range Over the Past 10 Years
Min: 11.67 Med: 22.82 Max: 32.25
Current: 15.72
XTER:EUZ's Interest Coverage is ranked worse than 50.21% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs XTER:EUZ: 15.72
Eckert & Ziegler SE (XTER:EUZ) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Eckert & Ziegler SE Interest Coverage Related Terms
Eckert & Ziegler SE Interest Coverage Historical Data
* Premium members only.
The historical data trend for Eckert & Ziegler SE's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
XTER:EUZ vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Eckert & Ziegler SE's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eckert & Ziegler SE Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Eckert & Ziegler SE's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eckert & Ziegler SE (XTER:EUZ) has a Interest Coverage of 15.27 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Eckert & Ziegler SE and its competitors. This is 33% below median its historical median of 22.82. Over the past decade, Eckert & Ziegler SE's Interest Coverage has ranged from 11.67 to 32.25. According to the industry distribution chart, Eckert & Ziegler SE ranks #234 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 50.2%.
Is Eckert & Ziegler SE's Interest Coverage too high?
Eckert & Ziegler SE's current Interest Coverage of 15.27 is 33% below median its 10-year median of 22.82. Over the past 10 years, this metric has ranged from a low of 11.67 to a high of 32.25. The Medical Devices & Instruments industry median Interest Coverage is 15.88. Eckert & Ziegler SE's value of 15.27 is 3.8% below this industry median. Based on the distribution chart, Eckert & Ziegler SE ranks #234 out of 466 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Eckert & Ziegler SE has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eckert & Ziegler SE's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eckert & Ziegler SE ranks #234 out of 466 companies for Interest Coverage. This places Eckert & Ziegler SE in the lower half of its industry. The industry median Interest Coverage is 15.88. Eckert & Ziegler SE's value of 15.27 is 3.8% below this benchmark. Historically, Eckert & Ziegler SE's own Interest Coverage has ranged from 11.67 to 32.25 over the past decade. While the company's 10-year median is 22.82 vs. the industry median of 15.88, Eckert & Ziegler SE has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eckert & Ziegler SE's current Interest Coverage of 15.27 is 3.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Eckert & Ziegler SE and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eckert & Ziegler SE's current Interest Coverage is 15.27, which is 33% below median its own 10-year median of 22.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eckert & Ziegler SE stock overvalued right now?
Based on GuruFocus' analysis, Eckert & Ziegler SE (XTER:EUZ) is currently considered Fairly Valued. The stock's GF Value™ is €16.25, compared to a current price of €15.31 — trading 5.8% below its estimated fair value. The current Interest Coverage is 15.27, which is 33% below median its 10-year median of 22.82 and 3.8% below the Medical Devices & Instruments industry median of 15.88. Eckert & Ziegler SE's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Eckert & Ziegler SE (XTER:EUZ), the current Interest Coverage is 15.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eckert & Ziegler SE (XTER:EUZ) Overvalued in 2026?
Based on GuruFocus' analysis, Eckert & Ziegler SE stock appears to be undervalued.
The current stock price of €15.31 is trading 5.8% below its estimated GF Value™ of €16.25.
GuruFocus considers Eckert & Ziegler SE to be Fairly Valued.
Key valuation signals for XTER:EUZ:
Interest Coverage: 15.27 (33% below median its 10-year median of 22.82)
GF Value™: €16.25 vs. price of €15.31 (5.8% below fair value)
Industry Position: 3.8% below the Medical Devices & Instruments median (#234 of 466)
No single metric tells the full story. See the XTER:EUZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eckert & Ziegler SE is a holding company with specialised in the processing of radioisotopes and the development, production and sale of isotope technology components, radiopharmaceuticals and related products. It is an international manufacturer of isotope technology components for medical, scientific, and industrial applications. The group's products are mainly used in cancer therapy, nuclear imaging, and industrial metrology. The company's segments are Medical, Isotope Products, and Other. The majority of revenue comes from Medical segment which provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. Geographically, the company generates a majority of its revenue from Europe and then North America, Asia/Pacific, and other.
98GF Score
Get the complete analysis for XTER:EUZ
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:EUZ has been successfully added to your 
